{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T18:08:38Z","timestamp":1781201318867,"version":"3.54.1"},"update-to":[{"DOI":"10.1371\/journal.pntd.0013878","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000}}],"reference-count":26,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Directorate-General for Development Cooperation and Humanitarian Aid (DGD), Belgium","award":["BE-BCE_KBO-0410057701-prg2022-5-ET"],"award-info":[{"award-number":["BE-BCE_KBO-0410057701-prg2022-5-ET"]}]}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Visceral leishmaniasis (VL) remains a major public health challenge in East Africa, particularly in Ethiopia. Clinical trials on VL often exclude patients with severe comorbidities or laboratory abnormalities, limiting the generalizability of evidence used to guide real-world management. We comprehensively characterised the clinical profile, treatment outcomes, and mortality of VL patients treated in a referral centre.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methodology and principal findings<\/jats:title>\n                    <jats:p>This prospective cohort study enrolled patients at the Leishmaniasis Research and Treatment Center (LRTC), University of Gondar (02\/2023-06\/2024). All VL cases fulfilling eligibility criteria underwent detailed clinical, laboratory, and radiological assessments. VL treatment followed WHO guidelines. Outcomes, adverse events, and supportive care measures were recorded during treatment and over a 12-month follow-up period. Patients meeting at least one exclusion criterion (e.g., comorbidities, clinical signs of severe VL) of standard phase III VL treatment trials were defined as trial-ineligible patients and compared with trial-eligible patients. A total of 314 VL patients, mostly young adult males (median age 22 years), were enrolled. Of these, 21 (6.7%) had HIV co-infection; 204 (65%) met\u2009\u2265\u20091 key exclusion criterion typically used in VL clinical trials. Trial-ineligible patients had high parasitemia, more concurrent infections, more pronounced clinical and laboratory abnormalities and a higher need of supportive care measures including systemic antibiotics and blood transfusion. Overall cure rate was 90.1%. Mortality after the first VL treatment course was 6.4%, ranging from 1.8% in trial-eligible patients to 8.8% in trial-ineligible patients. Leading causes of death included severe bacterial infections, acute liver failure and haemorrhagic complications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These findings underscore the severity and complexity of VL in routine care in our study population, and highlight the limitations of current trial populations to inform broader clinical practice. Strengthening supportive care and expanding research inclusivity designed to respond to the needs of this patient population are critical to achieve VL elimination targets.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pntd.0013878","type":"journal-article","created":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T17:46:56Z","timestamp":1780681616000},"page":"e0013878","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Severe visceral leishmaniasis in Ethiopia: Outcomes, co-infections and mortality in a prospective real-world cohort"],"prefix":"10.1371","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0845-4539","authenticated-orcid":true,"given":"Eleni","family":"Ayele","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saskia van","family":"Henten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Desalew Getahun","family":"Ayalew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saba","family":"Atnafu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asnakew Engidaw","family":"Mereed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hana","family":"Yohannes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tigist","family":"Mekonnen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadfe","family":"Bogale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aman","family":"Mossa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gebrehiwot Lema","family":"Legese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jemal","family":"Yasin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Berens-Riha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thao-Thy","family":"Pham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl","family":"Boodman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annelies","family":"Mondelaers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wim J.","family":"Adriaensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sa\u00efd","family":"Abdellati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ermias","family":"Diro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rezika","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiana","family":"Alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mezgebu Silamsaw","family":"Asres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myrthe","family":"Pareyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mekibib","family":"Kassa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan van","family":"Griensven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,6,5]]},"reference":[{"issue":"40","key":"pntd.0013878.ref001","first-page":"471","article-title":"Global leishmaniasis surveillance, 2022: assessing trends over the past 10 years","volume":"98","author":"World Health Organization","year":"2023","journal-title":"Weekly Epidemiological Record"},{"issue":"45","key":"pntd.0013878.ref002","first-page":"535","article-title":"Global leishmaniasis surveillance update, 2024: consolidating gains and new initiatives","volume":"100","author":"World Health Organization","year":"2025","journal-title":"Weekly Epidemiological Record"},{"key":"pntd.0013878.ref003","volume-title":"Strategic framework for the elimination of visceral leishmaniasis as a public health problem in Eastern Africa, 2023\u20132030","author":"World Health Organization","year":"2023"},{"key":"pntd.0013878.ref004","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1186\/1756-3305-5-240","article-title":"The burden of neglected tropical diseases in Ethiopia, and opportunities for integrated control and elimination","volume":"5","author":"K Deribe","year":"2012","journal-title":"Parasit Vectors"},{"key":"pntd.0013878.ref005","volume-title":"The Third National Neglected Tropical Diseases Strategic Plan 2021\u20132025","author":"Federal Ministry of Health E","year":"2021"},{"issue":"5","key":"pntd.0013878.ref006","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002875","article-title":"High parasitological failure rate of visceral leishmaniasis to sodium stibogluconate among HIV co-infected adults in Ethiopia","volume":"8","author":"E Diro","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0013878.ref007","doi-asserted-by":"crossref","first-page":"361058","DOI":"10.1155\/2014\/361058","article-title":"Bacterial sepsis in patients with visceral leishmaniasis in Northwest Ethiopia","volume":"2014","author":"M Endris","year":"2014","journal-title":"BioMed Research International"},{"issue":"11","key":"pntd.0013878.ref008","doi-asserted-by":"crossref","first-page":"871","DOI":"10.12980\/APJTB.4.2014C1133","article-title":"Characteristics of bacterial sepsis among patients with visceral leishmaniasis","volume":"4","author":"M Endris","year":"2014","journal-title":"Asian Pacific Journal of Tropical Biomedicine"},{"issue":"7","key":"pntd.0013878.ref009","doi-asserted-by":"crossref","first-page":"969","DOI":"10.3390\/pathogens12070969","article-title":"From Infection to Death: An Overview of the Pathogenesis of Visceral Leishmaniasis","volume":"12","author":"CHN Costa","year":"2023","journal-title":"Pathogens"},{"issue":"6","key":"pntd.0013878.ref010","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/0035-9203(95)90442-5","article-title":"Acute phase protein concentrations predict parasite clearance rate during therapy for visceral leishmaniasis","volume":"89","author":"KM Wasunna","year":"1995","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"1","key":"pntd.0013878.ref011","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.04298-14","article-title":"Systematic review of biomarkers to monitor therapeutic response in leishmaniasis","volume":"59","author":"AE Kip","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"pntd.0013878.ref012","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/s12917-018-1524-y","article-title":"Use of acute phase proteins for the clinical assessment and management of canine leishmaniosis: general recommendations","volume":"14","author":"JJ Ceron","year":"2018","journal-title":"BMC Vet Res"},{"issue":"8","key":"pntd.0013878.ref013","article-title":"Point-of-Care Biomarkers to Guide Antibiotic Prescription for Acute Febrile Illness in Sub-Saharan Africa: Promises and Caveats","volume":"7","author":"J van Griensven","year":"2020","journal-title":"Open Forum Infect Dis"},{"issue":"2","key":"pntd.0013878.ref014","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1179\/2047773213Y.0000000078","article-title":"Serum cytokines associated with severity and complications of kala-azar","volume":"107","author":"DL Costa","year":"2013","journal-title":"Pathog Glob Health"},{"issue":"1","key":"pntd.0013878.ref015","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1177\/0049475520967239","article-title":"Rare association of consumptive coagulopathy in visceral leishmaniasis: A case report","volume":"51","author":"E de Santana Ferreira","year":"2021","journal-title":"Trop Doct"},{"issue":"6","key":"pntd.0013878.ref016","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1136\/jcp.47.6.547","article-title":"Liver morphology and function in visceral leishmaniasis (Kala-azar)","volume":"47","author":"IA El Hag","year":"1994","journal-title":"Journal of Clinical Pathology"},{"issue":"11","key":"pntd.0013878.ref017","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.trstmh.2010.07.007","article-title":"Safety and effectiveness of meglumine antimoniate in the treatment of Ethiopian visceral leishmaniasis patients with and without HIV co-infection","volume":"104","author":"W Hailu","year":"2010","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"4","key":"pntd.0013878.ref018","first-page":"323","article-title":"Clinical presentation of visceral leishmaniasis in Kenya: a prospective study of 64 patients","volume":"35","author":"PA Kager","year":"1983","journal-title":"Trop Geogr Med"},{"issue":"3","key":"pntd.0013878.ref019","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1590\/S0036-46651987000300003","article-title":"Histopathological patterns of the liver involvement in visceral leishmaniasis","volume":"29","author":"MI Duarte","year":"1987","journal-title":"Rev Inst Med Trop Sao Paulo"},{"issue":"2","key":"pntd.0013878.ref020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0286233","article-title":"Traditional herbal medicine use doubled the risk of multi-organ dysfunction syndrome in children: A prospective cohort study","volume":"19","author":"NW Teshager","year":"2024","journal-title":"PLoS One"},{"issue":"3","key":"pntd.0013878.ref021","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s11239-005-0347-4","article-title":"Budd-Chiari syndrome associated with visceral leishmaniasis and factor V Leiden mutation","volume":"18","author":"E G\u00fcrkan","year":"2004","journal-title":"J Thromb Thrombolysis"},{"issue":"2","key":"pntd.0013878.ref022","first-page":"6403","article-title":"Evaluation of cardiopulmonary biomarkers during different stages of canine visceral leishmaniasis","volume":"23","author":"C Balikci","year":"2018","journal-title":"Revista MVZ C\u00f3rdoba"},{"issue":"11","key":"pntd.0013878.ref023","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006778","article-title":"Barriers to access to visceral leishmaniasis diagnosis and care among seasonal mobile workers in Western Tigray, Northern Ethiopia: A qualitative study","volume":"12","author":"RM Coulborn","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0013878.ref024","volume-title":"Guideline for diagnosis, treatment and prevention of leishmaniasis in Ethiopia","author":"Federal Ministry of Health E","year":"2013"},{"key":"pntd.0013878.ref025","doi-asserted-by":"crossref","first-page":"105474","DOI":"10.1016\/j.ebiom.2024.105474","article-title":"Prediction of visceral leishmaniasis development in a highly exposed HIV cohort in Ethiopia based on Leishmania infection markers: results from the PreLeisH study","volume":"110","author":"J van Griensven","year":"2024","journal-title":"EBioMedicine"},{"issue":"11","key":"pntd.0013878.ref026","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0011780","article-title":"Safety and efficacy of paromomycin\/miltefosine\/liposomal amphotericin B combinations for the treatment of post-kala-azar dermal leishmaniasis in Sudan: A phase II, open label, randomized, parallel arm study","volume":"17","author":"BM Younis","year":"2023","journal-title":"PLoS Negl Trop Dis"}],"updated-by":[{"DOI":"10.1371\/journal.pntd.0013878","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000}}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0013878","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T17:51:56Z","timestamp":1781200316000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0013878"}},"subtitle":[],"editor":[{"given":"Elise M.","family":"O\u2019Connell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,6,5]]},"references-count":26,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6,5]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0013878","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,5]]}}}